Código QR (código de barras bidimensional)

Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trialResearch in context

Summary: Background: The PHILA study suggests that pyrotinib, trastuzumab, and docetaxel significantly improved progression-free survival (PFS) compared with placebo, trastuzumab, and docetaxel in patients with untreated HER2-positive metastatic breast cancer. In this study, we aimed to investigate...

Fuld beskrivelse

Na minha lista:
Principais autores: Shuning Liu, Bo Lan, Yuanyi Wang, Tao Yang, Lixi Li, Hewei Ge, Cheng Zeng, Binghe Xu, Haili Qian, Fei Ma
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2024-11-01
Serier:EBioMedicine
Fag:
PHILA study
Pyrotinib
Trastuzumab
HER2-positive breast cancer
Online adgang:http://www.sciencedirect.com/science/article/pii/S2352396424004158
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker